Target Detachable Coils: TARGET HELICAL NANO 1 MM X 1 CM
Medical device recall Z-2165-2016. Published in FDA’s Enforcement Report on Jul 20, 2016.
No Watch here, and no alerts: openFDA asks that its enforcement data “should not be used as a method to collect data to issue alerts to the public, nor should it be used to track the lifecycle of a recall” (openFDA). For FDA’s own recall emails, subscribe at FDA. FDA’s own record is on accessdata.fda.gov.
The short answer
Published in FDA’s Enforcement Report on Jul 20, 2016. Copied from openFDA on Oct 20, 2026.
- Class II FDA’s class
- Terminated its status, in FDA’s file
- Nationwide FDA’s word for where it went
- 45,302 (8,188 in the U.S.) - total, all model numbers how much, in FDA’s words
Every line below is in FDA’s own words, with its source beside it. FDA’s terms are explained in FDA’s own words.
How serious is it, by FDA’s class?
Class II, the middle of FDA’s three classes.
“Products that might cause a temporary health problem, or pose only a slight threat of a serious nature. Example: a drug that is under-strength but that is not used to treat life-threatening situations.”
openFDA, in plain words, its enforcement report fields.
“Class II is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.”
FDA’s rule, 21 CFR 7.3(m)(2), eCFR.
What these words mean is quoted from openFDA’s field reference and 21 CFR 7.3.
What’s wrong with it?
Stryker Neurovascular has become aware that some units of Target Nano product do not have the intended stretch resistance. The sutures inside the coil that provide stretch resistance may have been damaged during manufacturing which can lead to an increased occurrence of coil stretching.
FDA, Device recall enforcement reports. Released Oct 14, 2026. Updated weekly.
Which ones are recalled?
Target Detachable Coils: TARGET HELICAL NANO 1 MM X 1 CM MODEL Number:M0035431010 Neurology: Target Detachable Coils are intended to endovascularly obstruct or occlude blood flow in vascular abnormalities of the neurovascular and peripheral vessels.
45,302 (8,188 in the U.S.) - total, all model numbers, in FDA’s words.
FDA, Device recall enforcement reports. Released Oct 14, 2026. Updated weekly.
Codes to check against yours
MODEL Number: M0035431010 Lot Number/Expiration Date: 18784731 31-Jan-19 18767279 31-Dec-18 18685490 30-Nov-18 18592036 30-Sep-18 18818328 31-Jan-19 18723284 30-Nov-18 18630215 31-Oct-18 18601959 30-Sep-18 18414374 31-May-18 18748453…
Every code shown here, 1,479 characters
MODEL Number: M0035431010 Lot Number/Expiration Date: 18784731 31-Jan-19 18767279 31-Dec-18 18685490 30-Nov-18 18592036 30-Sep-18 18818328 31-Jan-19 18723284 30-Nov-18 18630215 31-Oct-18 18601959 30-Sep-18 18414374 31-May-18 18748453 31-Dec-18 18730570 30-Nov-18 18606940 30-Sep-18 18403443 31-May-18 18818502 31-Jan-19 18796245 31-Jan-19 18627513 31-Oct-18 18601901 30-Sep-18 18581353 30-Sep-18 18484777 31-Jul-18 18818676 31-Jan-19 18777759 31-Dec-18 18484661 31-Jul-18 18429414 30-Jun-18 18801963 31-Jan-19 18803278 31-Jan-19 18786355 31-Jan-19 18776711 31-Dec-18 18767778 31-Dec-18 18723052 30-Nov-18 18539797 31-Aug-18 18417674 31-May-18 18831860 31-Jan-19 18818850 31-Jan-19 18739085 30-Nov-18 18833082 31-Jan-19 18748163 31-Dec-18 18738163 30-Nov-18 18602017 30-Sep-18 18581469 31-Aug-18 18543905 31-Aug-18 18450658 30-Jun-18 19002735 30-Apr-19 18941882 31-Mar-19 18941418 31-Mar-19 18930269 31-Mar-19 18894264 28-Feb-19 18893885 28-Feb-19 18885637 28-Feb-19 18957343 31-Mar-19 18956763 31-Mar-19 18940954 31-Mar-19 18857373 28-Feb-19 18975521 30-Apr-19 18975084 30-Apr-19 18847507 28-Feb-19 18930614 31-Mar-19 18847275 31-Jan-19 19002909 30-Apr-19 18929924 31-Mar-19 18847333 31-Jan-19 19062880 31-May-19 19002851 30-Apr-19 19002677 30-Apr-19 18974210 30-Apr-19 18930959 31-Mar-19 18906932 31-Mar-19 19046992 31-May-19 19002793 30-Apr-19 18893506 28-Feb-19 18887051 28-Feb-19 18847391 28-Feb-19 18984787 30-Apr-19 19037618 31-May-19 19064752 31-May-19 18894643 28-Feb-19.
Copied exactly as FDA lists them: lot and serial numbers, dates and other codes on the product or its label.
Where did it go?
FDA’s words for the “general area of initial distribution”: where the firm first shipped it.
Worldwide Distribution - US (nationwide) and Australia, Austria, Belgium, Brazil, Bulgaria, Canada, Canary Islands, Chile, China, Colombia, Croatia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Greece, Hong Kong, Hungary, India, Ireland, Italia, Japan,Latvia, Lebanon, Libyan Arab Jamahiriya, Lithuania, Luxembourg, Mexico,Netherlands, Norway, Peru, Philippines, Poland, Portugal, Russia, Saudi Arabia, Singapore, Slovakia, Slovenia, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, United Arab Emirates, United Kingdom, United States, Uruguay, and Vietnam.
These words name no state.
What FDA means by nationwide
“The term “nationwide” is defined to mean the fifty states or a significant portion. Note that subsequent distribution by the consignees to other parties may not be included.”
openFDA, its enforcement report fields.
The words say it went outside the United States too.
What these words mean is quoted from openFDA’s field reference and 21 CFR 7.3.
Is it still going on?
Terminated, in FDA’s file.
“FDA has determined that all reasonable efforts have been made to remove or correct the violative product in accordance with the recall strategy, and proper disposition has been made according to the degree of hazard.”
openFDA, on “Terminated”, its enforcement report fields.
What these words mean is quoted from openFDA’s field reference and 21 CFR 7.3.
- The firm began the recall on Jun 6, 2016.
- FDA classified it on Jul 11, 2016.
- FDA’s Enforcement Report published it on Jul 20, 2016.
- FDA terminated it on Mar 3, 2017.
FDA, Device recall enforcement reports. Released Oct 14, 2026. Updated weekly.
Who is recalling it?
- Stryker Neurovascular, of Fremont, CA.
- Who began it, in FDA’s words: Voluntary: Firm initiated.
- How the firm first told its customers: Letter.
FDA, Device recall enforcement reports. Released Oct 14, 2026. Updated weekly.
What this record can’t tell you
- Whether your own one is affected: compare the codes, dates and numbers above with yours. When unsure, ask the firm or the store.
- Where it went after the firm’s first shipments. FDA’s words cover the firm’s initial distribution, and, in FDA’s words, “subsequent distribution by the consignees to other parties may not be included.”
- How many have been returned, corrected or destroyed: FDA’s report doesn’t say.
- Whether anyone was hurt or fell ill: the report doesn’t say.
- How current it is: openFDA publishes FDA’s Enforcement Report weekly, after FDA does, and a firm can announce a recall weeks before it appears there. openFDA’s own caution: “This data should not be used as a method to collect data to issue alerts to the public, nor should it be used to track the lifecycle of a recall.”
- A product with no recall here isn’t safe by that: FDA’s report lists the recalls FDA classified, and when.
Hearth Record wrote these lines; the quotations are FDA’s.
Sources
-
U.S. Food and Drug Administration, Device recall enforcement reports.
Released Oct 14, 2026 and checked Oct 20, 2026. Updated weekly. Public domain (CC0 1.0, openFDA). FDA asks that nothing suggest it endorses this site.
Recalls of food, medicines, medical devices, pet food and animal drugs are from the U.S. Food and Drug Administration (FDA). FDA does not endorse Hearth Record. openFDA: “Do not rely on openFDA to make decisions regarding medical care.” Copied on Oct 20, 2026.